Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case.
Gaucher disease
hemochromatosis
hyperferritinemia
misdiagnosis
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
15 Jun 2022
15 Jun 2022
Historique:
received:
05
05
2022
revised:
03
06
2022
accepted:
13
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Gaucher disease is a disorder of lysosomes caused by a functional defect of the glucocerebrosidase enzyme. The disease is mainly due to mutations in the GBA1 gene, which determines the gradual storage of glucosylceramide substrate in the patient's macrophages. In this paper, we describe the case of a 38-year-old man who clinically presented with hyperferritinemia, thrombocytopenia, leukopenia, anemia and mild splenomegaly; a diagnosis of hemochromatosis was made 10 years earlier. Re-evaluation of the clinical case led to a suspicion of Gaucher disease, which was confirmed by enzymatic analysis, which was found to be below the normal range, and genetic evaluation, which identified compound heterozygosity N370S/RecNciI. We know that patients suffering from Gaucher disease can also have high ferritin levels. Even if the mechanism underlying the changes in iron metabolism is not yet elucidated, the chronic mild inflammatory state present in these patients probably causes the storage of ferritin in macrophages, resulting in hyperferritinemia. Therefore, in the presence of few typical signs and symptoms of the disease should raise an alarm bell in the clinicians, inducing clinical suspicion of Gaucher disease. Misdiagnosis and diagnostic delay in metabolic diseases could cause irreversible organ damage and delay the start of specific therapy for these patients.
Identifiants
pubmed: 35741435
pii: biology11060914
doi: 10.3390/biology11060914
pmc: PMC9220320
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Br J Haematol. 2018 Aug;182(4):467-480
pubmed: 29808905
Am J Hematol. 2011 Jan;86(1):110-5
pubmed: 21080341
Orphanet J Rare Dis. 2012 Oct 09;7:77
pubmed: 23046562
Hematology. 2017 Mar;22(2):65-73
pubmed: 27762169
Clin Chem Lab Med. 2019 Nov 26;57(12):1863-1874
pubmed: 31091195
Blood Cells Mol Dis. 2007 Jul-Aug;39(1):119-23
pubmed: 17395504
Lakartidningen. 2012 Nov 14-20;109(46):2097-9
pubmed: 23259216
Arch Inst Pasteur Tunis. 2007;84(1-4):65-70
pubmed: 19388585
Blood Cells Mol Dis. 2012 Jun 15;49(1):53-7
pubmed: 22560483
Pathol Biol (Paris). 2013 Apr;61(2):59-63
pubmed: 22542428
Blood Cells Mol Dis. 2018 Feb;68:35-42
pubmed: 27816428
Lancet. 2008 Oct 4;372(9645):1263-71
pubmed: 19094956
Blood. 2010 Sep 2;116(9):1574-84
pubmed: 20472835
Clin Chim Acta. 2002 Mar;317(1-2):191-7
pubmed: 11814475
Crit Rev Oncog. 2013;18(3):163-75
pubmed: 23510062
Int J Mol Sci. 2017 Feb 17;18(2):
pubmed: 28218669
J Inherit Metab Dis. 2018 Mar;41(2):209-219
pubmed: 29143201
Blood Cells Mol Dis. 1997 Aug;23(2):201-12
pubmed: 9236158
Clin Biochem. 2021 Jan;87:79-84
pubmed: 33188770
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2349-52
pubmed: 3353383
Discov Med. 2012 Oct;14(77):273-81
pubmed: 23114583
Am J Hum Genet. 1990 Jul;47(1):79-86
pubmed: 2349952
Biochim Biophys Acta. 2007 Jul;1772(7):788-96
pubmed: 17499484
Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):287-98
pubmed: 10744424
Clin Chim Acta. 2009 Aug;406(1-2):86-8
pubmed: 19501579
Int J Neonatal Screen. 2019 Jun 21;5(2):24
pubmed: 33072983
Eur Cytokine Netw. 1999 Jun;10(2):205-10
pubmed: 10400826
Am J Hematol. 2020 May;95(5):570-576
pubmed: 32031266
Blood Cells Mol Dis. 2014 Dec;53(4):171-5
pubmed: 25153906